Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Pilot Study Testing Benefits of Ursolic Acid (UA) as a Countermeasure To Myopenia and Insulin Resistance in Chronic Spinal Cord Injury (SCI)

NCT05776862 is registered in ClinicalTrials.gov with University of Miami as lead sponsor.

NCT NCT05776862
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05776862 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Pilot Study Testing Benefits of Ursolic Acid (UA) as a Countermeasure To Myopenia and Insulin Resistance in Chronic Spinal Cord Injury (SCI)
Lead sponsor
University of Miami
Phase
Phase 2
Overall status
Completed
Start date
March 27, 2023
Completion date
January 29, 2025
Enrollment
10 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

atrophy, muscular, insulin resistance, muscle loss, paraplegia, spinal cord injuries, tetraplegia